These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 10639319

  • 1. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.
    Hooper JW, Custer DM, Schmaljohn CS, Schmaljohn AL.
    Virology; 2000 Jan 20; 266(2):329-39. PubMed ID: 10639319
    [Abstract] [Full Text] [Related]

  • 2. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC, Goenaga J, Wittek R, Rindisbacher L.
    Virology; 1999 Feb 01; 254(1):71-80. PubMed ID: 9927575
    [Abstract] [Full Text] [Related]

  • 3. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.
    Golden JW, Josleyn MD, Hooper JW.
    Vaccine; 2008 Jun 25; 26(27-28):3507-15. PubMed ID: 18485547
    [Abstract] [Full Text] [Related]

  • 4. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates.
    Hooper JW, Custer DM, Thompson E.
    Virology; 2003 Feb 01; 306(1):181-95. PubMed ID: 12620810
    [Abstract] [Full Text] [Related]

  • 5. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
    Pulford DJ, Gates A, Bridge SH, Robinson JH, Ulaeto D.
    Vaccine; 2004 Sep 03; 22(25-26):3358-66. PubMed ID: 15308360
    [Abstract] [Full Text] [Related]

  • 6. Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene.
    Aldaz-Carroll L, Whitbeck JC, Ponce de Leon M, Lou H, Pannell LK, Lebowitz J, Fogg C, White CL, Moss B, Cohen GH, Eisenberg RJ.
    Virology; 2005 Oct 10; 341(1):59-71. PubMed ID: 16083934
    [Abstract] [Full Text] [Related]

  • 7. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.
    Clark KM, Johnson JB, Kock ND, Mizel SB, Parks GD.
    Virology; 2011 Oct 25; 419(2):97-106. PubMed ID: 21885079
    [Abstract] [Full Text] [Related]

  • 8. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.
    Kaufman DR, Goudsmit J, Holterman L, Ewald BA, Denholtz M, Devoy C, Giri A, Grandpre LE, Heraud JM, Franchini G, Seaman MS, Havenga MJ, Barouch DH.
    J Virol; 2008 Jul 25; 82(14):6829-37. PubMed ID: 18448519
    [Abstract] [Full Text] [Related]

  • 9. Extracellular enveloped vaccinia virus escapes neutralization.
    Ichihashi Y.
    Virology; 1996 Mar 15; 217(2):478-85. PubMed ID: 8610439
    [Abstract] [Full Text] [Related]

  • 10. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
    Putnak R, Fuller J, VanderZanden L, Innis BL, Vaughn DW.
    Am J Trop Med Hyg; 2003 Apr 15; 68(4):469-76. PubMed ID: 12875299
    [Abstract] [Full Text] [Related]

  • 11. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.
    Vanderzanden L, Bray M, Fuller D, Roberts T, Custer D, Spik K, Jahrling P, Huggins J, Schmaljohn A, Schmaljohn C.
    Virology; 1998 Jun 20; 246(1):134-44. PubMed ID: 9657001
    [Abstract] [Full Text] [Related]

  • 12. Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5R.
    Gurt I, Abdalrhman I, Katz E.
    Antiviral Res; 2006 Mar 20; 69(3):158-64. PubMed ID: 16406098
    [Abstract] [Full Text] [Related]

  • 13. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.
    Raviprakash K, Marques E, Ewing D, Lu Y, Phillips I, Porter KR, Kochel TJ, August TJ, Hayes CG, Murphy GS.
    Virology; 2001 Nov 10; 290(1):74-82. PubMed ID: 11883007
    [Abstract] [Full Text] [Related]

  • 14. The exit of vaccinia virus from infected cells.
    Smith GL, Law M.
    Virus Res; 2004 Dec 10; 106(2):189-97. PubMed ID: 15567497
    [Abstract] [Full Text] [Related]

  • 15. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
    Paran N, Suezer Y, Lustig S, Israely T, Schwantes A, Melamed S, Katz L, Preuss T, Hanschmann KM, Kalinke U, Erez N, Levin R, Velan B, Löwer J, Shafferman A, Sutter G.
    J Infect Dis; 2009 Jan 01; 199(1):39-48. PubMed ID: 19012492
    [Abstract] [Full Text] [Related]

  • 16. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 01; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 17. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
    Fang M, Cheng H, Dai Z, Bu Z, Sigal LJ.
    Virology; 2006 Feb 05; 345(1):231-43. PubMed ID: 16256161
    [Abstract] [Full Text] [Related]

  • 18. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
    Ganges L, Barrera M, Núñez JI, Blanco I, Frias MT, Rodríguez F, Sobrino F.
    Vaccine; 2005 May 25; 23(28):3741-52. PubMed ID: 15882536
    [Abstract] [Full Text] [Related]

  • 19. Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.
    Chen CH, Wang TL, Ji H, Hung CF, Pardoll DM, Cheng WF, Ling M, Wu TC.
    Gene Ther; 2001 Jan 25; 8(2):128-38. PubMed ID: 11313782
    [Abstract] [Full Text] [Related]

  • 20. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
    Bell E, Shamim M, Whitbeck JC, Sfyroera G, Lambris JD, Isaacs SN.
    Virology; 2004 Aug 01; 325(2):425-31. PubMed ID: 15246280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.